Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Sign In
    New user? Click here to register.Have you forgotten your password?
Repository logo
  • Institutions & Repositories
  • Query NERD by:
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Sign In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Danjuma NM"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    Item
    Antinociceptive activity of methanol extract of Chlorophytum alismifolium tubers in murine model of pain: Possible involvement of α2-adrenergic receptor and KATP channels
    (2020) Abubakar A; Nazifi AB; Odoma S; Shehu S; Danjuma NM
    The tubers of Chlorophytum alismifolium are used in Nigerian Herbal Medicine for the management of diabetes mellitus, painful and inflammatory conditions. The antinociceptive activity has been validated but the mechanism of this activity is yet to be explored. This study therefore, aimed to investigate the probable mechanism(s) of the antinociceptive activity of C. alismifolium tubers using experimental animal model of pain. HPLC and GC-MS analyses were carried out on the extract. Antinociceptive activity was investigated using acetic acid-induced writhing response test in mice. Three groups of mice were orally administered distilled water (10 ml/kg), C. alismifolium (400 mg/kg) and morphine (10 mg/kg) 60 min before administration of acetic acid and the resulting writhing were counted for 10 min. To establish the probable mechanism(s) of action of C. alismifolium, separate groups of animals were pretreated intraperitoneally with naloxone (2 mg/kg), prazosin (1 mg/kg), yohimbine (1 mg/kg), propranolol (20 mg/kg) and glibenclamide (5 mg/kg) 15 min before C. alismifolium administration. HPLC chromatogram of the extract revealed seventeen characteristic peaks with retention times ranging between 2.1 and 7.4 min. Administration of C. alismifolium significantly (p < 0.01) reduced the mean number of writhes compared to control group. Pretreatment with yohimbine and glibenclamide significantly (p < 0.05 and p < 0.01 respectively) reduced the antinociceptive activity of extract-alone treated group. However, pretreatment with prazosin, naloxone and propranolol showed no effect on its analgesic activity. The findings from this research revealed the possible involvement of α2-adrenergic receptor and KATP channels in the antinociceptive activity of Chlorophytum alismifolium tuber extract.
THE NERD SYSTEM

Nigeria Education Repository and Databank (NERD) is the official unified digital platform and a one-stop-shop for the national management, administration, and preservation of education data, records, documents and audio-visual assets as a national reference point for education data consistency - supporting the education sector and library services.

QUICK MENU
  • About NERD
  • Contact and Support
  • Other NERD Services
  • Internal/External Examiner Sign up
  • Student/Lecturer's Sign up
  • Regulatory Agencies
ONGOING ACTION
  • Register Your Institution
  • Training
  • Donate Manuscript
  • Donate Parents' Works
  • Investors
  • Annual Prize and Award
  • Thesis & Dissertation
  • Annual Competition
  • Lecturers' Scholarly Article Prizes
  • Essay Prizes
DIGITAL BANK TOOLS
  • Plagiarism Check
  • NCMVS
  • Publish on NERD
  • Peer Review Publications
  • Futile Hypothesis
  • NERD Receipt
  • InfoGraphics

NERD System Copyright © Federal Ministry of Education.

  • Cookie settings  | 
  • Terms and Conditions  |  
  • End Users Agreement  | 
  • Privacy Policy